by Marisa Messick | Oct 30, 2024 | Blog
Read the full story here Authored by Elizabeth Duncan, Former Cortado Ventures Intern As we all know, the COVID-19 pandemic required pharmaceutical companies to put to the test how fast vaccines, treatments, and diagnostics could be developed, tested, and...
by Marisa Messick | Oct 24, 2024 | Podcasts
New research on Adverse Childhood Experiences (ACEs) demonstrates an overwhelming negative correlation between the severity/frequency of childhood trauma and lifetime well-being outcomes. Ed Long overcame childhood trauma to pursue a Master’s of Public...
by Marisa Messick | Oct 10, 2024 | Podcasts
Tech exit to selling “commoditized” water bottles on Amazon? Mike Beckham must be crazy! After 9 years of rapid growth with his company Simple Modern, Mike has proved his doubters wrong by leaning into competition to eliminate market risk. Tune in to hear...
by Marisa Messick | Oct 10, 2024 | Blog
Read the full story here Authored by Kingsley Uzogor, Former Cortado Ventures Intern You are in one of these two camps — those who believe that clean energy is the future and those who think the future is uncertain. VCs were in the first camp in 2006. By 2011,...
by Marisa Messick | Oct 1, 2024 | Newsletters
Why We Invested in Prelude, EXUM Instruments Highlight, Boddle Named as Finalist for $500,000 Yass Prize, and more. Cortado Ventures Oct 09, 2024 Share BLUF (Bottom Line Up Front) Read the latest Why We Invested blog featuring our investment in Prelude. Our 2024-2025...
